Diffusion Pharmaceuticals Inc.
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. The company is also developing DFN-529, a phosphoinositide 3-kinase/Akt/mechanistic target of rapamycin pathway inhibitor. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia. Show More...
-
Website http://www.diffusionpharma.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 9.25 USD
-
Last Updated 18-10-2023
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -2099.99 -3899.98 -1223.99 -150.0 -150.0 -38.47 -26.4 -29.11 -8.21 -1.76 -1.02 Dividends USD Payout Ratio % * Shares Mil 1.0 1.0 3.0 7.0 14.0 Book Value Per Share * USD -135.37 859.6 -3096.55 -162.26 344.88 153.66 16.65 6.57 6.19 0.4 0.3 Free Cash Flow Per Share * USD -485.93 -2008.54 -722.27 -181.93 -108.93 -70.79 -30.67 -14.91 -3.81 -2.71 Return on Assets % -170.6 -342.46 -240.1 -25.36 -46.96 -75.99 -96.45 -12.0 -120.07 -55.77 -62.68 Financial Leverage (Average) 2.84 1.12 1.21 1.9 1.23 1.17 1.2 1.18 Return on Equity % -64.33 -87.25 -140.78 -17.21 -144.53 -66.02 -75.25 Return on Invested Capital % -63.3 -87.25 -118.14 -15.76 -144.53 -65.12 -73.97 Interest Coverage -102.33 -36.64 -103.64 -4.06 -61.78 -618.87 -49.41 Current Ratio 0.12 0.05 0.02 0.34 10.34 10.11 0.36 3.59 11.09 8.51 9.11 Quick Ratio 0.02 0.02 0.03 9.36 9.97 0.35 3.31 9.94 8.24 8.41 Debt/Equity 0.06 0.010 0.010